Skip to content

    Tonix Pharmaceuticals Holding (TNXP) stock price & financials

    View TNXP earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance57.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $2.82M
    $2.58M
    $2.43M
    $2.00M
    $3.29M
    +16.6%
    $5.39M
    +108.8%
    $6.88M
    +183.2%
    $13.54M
    +577.9%
    Strengthening
    Operating Profit
    -$15.55M
    -$22.48M
    -$16.05M
    -$28.30M
    -$33.07M
    -112.6%
    -$48.29M
    -114.8%
    -$41.54M
    -158.7%
    -$42.53M
    -50.3%
    Weakening
    Net Profit
    -$14.21M
    -$22.11M
    -$16.83M
    -$28.27M
    -$32.01M
    -125.2%
    -$46.91M
    -112.2%
    -$40.19M
    -138.8%
    -$40.55M
    -43.4%
    Weakening
    EPS
    $-22.68
    $-2.84
    $-3.86
    $-3.59
    +84.2%
    $-2.93
    -3.2%
    $-2.44
    +36.8%
    Strengthening
    Other Income
    Interest
    $301.0K
    Depreciation
    Profit before Tax
    MarginsOPM
    -551.2%
    -870.6%
    -660.9%
    -1416.2%
    -1005.1%
    -82.4%
    -895.8%
    -2.9%
    -603.9%
    +8.6%
    -314.1%
    +77.8%
    Strengthening
    Tax
    ReturnsROIC
    1.5%
    2.4%
    1.8%
    3.0%
    3.4%
    +125.2%
    5.0%
    +112.2%
    4.3%
    +138.8%
    4.3%
    +43.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$25.03M$11.25M$77.07M$178.66M$120.23M$24.95M$98.78M$207.64M$176.23M
    Short-Term Investments
    Total Current Assets$26.06M$13.95M$87.99M$189.05M$130.78M$47.77M$119.00M$228.88M$203.43M
    Net PP&E$43.0K$390.0K$9.83M$51.47M$94.53M$94.85M$42.82M$46.00M$46.11M
    Goodwill$965.0K
    Intangibles$120.0K$120.0K$120.0K$120.0K$120.0K$9.74M$120.0K$120.0K$120.0K
    Total Assets$26.32M$14.56M$98.18M$240.90M$225.69M$154.46M$162.89M$277.17M$254.09M
    LiabilitiesTotal Current Liabilities$2.65M$5.13M$9.82M$21.72M$18.18M$18.88M$18.31M$30.84M$30.79M
    Short-Term Debt$2.35M$2.82M
    Long-Term Debt$6.56M$4.67M
    Long-Term Leases$6.0K$716.0K$467.0K$328.0K$632.0K$358.0K$1.18M$1.02M
    Total Liabilities$2.65M$5.14M$10.54M$22.18M$18.51M$48.93M$23.33M$32.02M$31.81M
    EquityCommon Stock & APIC$3.0K$9.0K$206.0K$16.0K$12.0K$3.0K$4.0K$13.0K$17.0K
    Retained Earnings-$188.45M-$217.07M-$267.53M-$359.82M-$470.04M-$600.66M-$730.69M-$854.72M-$935.46M
    Total Equity$23.66M$9.42M$87.65M$218.72M$207.18M$105.53M$139.56M$245.15M$222.28M
    HighlightsNet Cash / (Debt)$16.04M$91.29M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$23.97M-$26.68M-$48.57M-$75.56M-$98.05M-$102.00M-$60.92M-$99.84M-$152.99M
    Cash from Investing-$6.0K-$17.0K-$8.56M-$35.31M-$48.15M-$29.07M-$120.0K-$4.53M-$4.26M
    Cash from Financing$23.54M$12.92M$123.11M$212.49M$87.84M$36.52M$134.87M$214.53M$207.71M
    SummaryCapital Expenditure-$6.0K-$17.0K-$8.56M-$35.31M-$48.15M-$7.89M-$120.0K-$3.37M-$5.12M
    Free Cash Flow-$23.98M-$26.70M-$57.13M-$110.86M-$146.20M-$109.90M-$61.05M-$103.21M-$158.11M
    FCF Margin-1414.8%-604.8%-787.5%-543.3%

    Ratios